The Journal of Alzhemer's Disease
The Journal of Alzheimer's Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, hypotheses, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer's disease. Read more about the Journal of Alzheimer’s Disease HERE.
Read More...USF-Byrd Alzheimer's News
Dr. Morgan Discusses Alzheimer’s on Fox's "Your Turn"
International Conference on Alzheimer's Disease
Alzheimer’s Institute faculty and graduate students are attending and presenting their work at the 10th annual International Conference (ICAD www.alz.org/icad).
Rules Seek to Expand Diagnosis of Alzheimer’s
13 July 2010 New York Times article New York Time Experts predict a two- to threefold increase in the number of people with the disease if new guidelines are adopted, as expected.
Spinal-Fluid Test Is Found to Predict Alzheimer’s
Spinal-Fluid Test Is Found to Predict Alzheimer’s
NY Times By GINA KOLATA Published: August 9, 2010
“Researchers report that a spinal fluid test can be 100 percent accurate in identifying patients with significant memory loss who are on their way to developing Alzheimer’s disease.
Although there has been increasing evidence of the value of this and other tests in finding signs of Alzheimer’s, the study, which will appear Tuesday in the Archives of Neurology, shows how accurate they can be. The new result is one of a number of remarkable recent findings about Alzheimer’s.
After decades when nothing much seemed to be happening, when this progressive brain disease seemed untreatable and when its diagnosis could be confirmed only at autopsy, the field has suddenly woken up.
Alzheimer’s, medical experts now agree, starts a decade or more before people have symptoms. And by the time there are symptoms, it may be too late to save the brain. So the hope is to find good ways to identify people who are getting the disease, and use those people as subjects in studies to see how long it takes for symptoms to occur and in studies of drugs that may slow or stop the disease....” MORE FROM THE NEW YORK TIMES ON ALZHEIMER’S SPINAL FLUID TEST Read More...
